Scholarlink

<p>Since the “mesh pause” in 2018, our unit has provided three primary treatment options for stress urinary incontinence (SUI): laparoscopic colposuspension, autologous fascial sling (AFS), and urethral bulking agents. This study presents a comprehensive review of these procedures performed in our unit, evaluating their success and complication rates from 2019 to 2022. This retrospective study evaluates female stress urinary incontinence (SUI) procedures carried out at a single UK tertiary referral center between 2019 and 2022. The analysis includes patients who underwent treatment with urethral bulking agents, laparoscopic colposuspension, or autologous fascial sling (AFS) procedure, assessing success rates and complication rates of each procedure. A total of 75 bulking agent injections, 21 laparoscopic colposuspensions, and 11 autologous fascial sling (AFS) procedures were analyzed. The overall success rates at the 4-month follow-up were 90% for AFS, 71% for laparoscopic colposuspensions, and 69% for urethral bulking agents. All AFS procedures were primary interventions, while 83% of urethral bulking agents and 75% of laparoscopic colposuspensions were also primary procedures. Given the current “mesh pause,” AFS, urethral bulking agents, and laparoscopic colposuspensions serve as effective alternatives, each presenting unique benefits and limitations.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Surgical Management of Stress Urinary Incontinence in a Teaching Hospital: Outcomes and Considerations Post-“Mesh Pause”

  • 期刊论文

  • 发表日期：

    2025年5月1日

查看全文
  • Abayomi I. Alao,
  • Aashima Khan,
  • Bhawana Purwar,
  • Natali Chikhes,
  • Bivas Biswas,
  • Jaydip Dasgupta,
  • Panayoti Bachkangi

摘要

Since the “mesh pause” in 2018, our unit has provided three primary treatment options for stress urinary incontinence (SUI): laparoscopic colposuspension, autologous fascial sling (AFS), and urethral bulking agents. This study presents a comprehensive review of these procedures performed in our unit, evaluating their success and complication rates from 2019 to 2022. This retrospective study evaluates female stress urinary incontinence (SUI) procedures carried out at a single UK tertiary referral center between 2019 and 2022. The analysis includes patients who underwent treatment with urethral bulking agents, laparoscopic colposuspension, or autologous fascial sling (AFS) procedure, assessing success rates and complication rates of each procedure. A total of 75 bulking agent injections, 21 laparoscopic colposuspensions, and 11 autologous fascial sling (AFS) procedures were analyzed. The overall success rates at the 4-month follow-up were 90% for AFS, 71% for laparoscopic colposuspensions, and 69% for urethral bulking agents. All AFS procedures were primary interventions, while 83% of urethral bulking agents and 75% of laparoscopic colposuspensions were also primary procedures. Given the current “mesh pause,” AFS, urethral bulking agents, and laparoscopic colposuspensions serve as effective alternatives, each presenting unique benefits and limitations.